Department of Plastic and Reconstructive Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
Department of Plastic and Reconstructive Surgery, Center Hospital of National Center for Global Health and Medicine Plastic and Reconstructive Surgery, Tokyo, Japan.
J Surg Oncol. 2021 Mar;123(4):1067-1080. doi: 10.1002/jso.26364. Epub 2021 Jan 11.
Postoperative complications after flap-coverage in sarcoma treatment can postpone postoperative adjunct treatments. Here, we present our experience with the use of the superficial circumflex iliac artery perforator (SCIP) flap after sarcoma resection.
Patients undergoing immediate reconstruction surgery with a flap after sarcoma resection at a single institution from February 2017 to April 2020 were identified. Patient demographics, tumor characteristics, surgical characteristics, and complications were examined.
Thirty-five consecutive patients underwent reconstructions using a SCIP flap (34 free and one pedicled SCIP flaps). We also identified 47 consecutive patients who underwent reconstruction with other pedicled or free flaps over the same time period. No significant differences were found in patient age, gender, defect size, or operative time between these two groups. The incidences of overall complications (20/47 [42.6%] vs. 3/35 [8.5%], p < .001), flap dehiscence (7/47 [14.8%] vs. 0/35 [0%], p = .018), and total flap complications (15/47 [31.9%] vs. 2/35 [5.7%], p = .005) were statistically greater in the control group than in the SCIP group.
With its minimal postoperative complication rate both in the reconstruction site and the donor site, the SCIP flap can be considered an optimal reconstruction option after sarcoma resection.
肉瘤治疗中皮瓣覆盖后的术后并发症可能会延迟术后辅助治疗。在此，我们介绍了我们在肉瘤切除后使用旋髂浅动脉穿支（SCIP）皮瓣的经验。
在 2017 年 2 月至 2020 年 4 月期间，我们在一家机构中识别出了接受了皮瓣覆盖术的接受即刻重建手术的患者。检查了患者的人口统计学、肿瘤特征、手术特征和并发症。
35 例患者接受了 SCIP 皮瓣重建（34 例游离皮瓣和 1 例带蒂 SCIP 皮瓣）。我们还确定了在同一时期接受其他带蒂或游离皮瓣重建的 47 例连续患者。这两组患者在年龄、性别、缺损大小或手术时间方面没有显著差异。两组的总体并发症发生率（20/47[42.6%]与 3/35[8.5%]，p<0.001）、皮瓣裂开发生率（7/47[14.8%]与 0/35[0%]，p=0.018）和总皮瓣并发症发生率（15/47[31.9%]与 2/35[5.7%]，p=0.005）差异有统计学意义。
SCIP 皮瓣的术后并发症发生率在重建部位和供区都较低，可作为肉瘤切除后重建的理想选择。
